PDF Infomation about enterprise

Foundation year: 1946

NACE classifier: Manufacture of pharmaceutical preparations

Valid certificates:

EU Good Manufacturing Practice certificates for finished dosage forms and active pharmaceutical ingredients
EU Good Manufactiring Certificate for Pharmaceutical Wholesaler
Russian Certificate of good Manufacturing Practice for finished dosage forms
ISO 9001 Quality Management System Certificate
ISO 14001 Environmental Mangement Systeme Certificate
ISO 50001 Energy Management Certificate
Successful PMDA and US FDA
Saudi Food and Drug Administration Certificate

Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2017 to 2021.

Copy data

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2017 to 2021.

Copy data

“Grindeks” is an international pharmaceutical company focused on research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The Group of “Grindeks” has four subsidiary companies in Latvia, Estonia and Slovakia as well as representative offices in 12 countries.
“Grindeks” specializes in the heart and cardiovascular, CNS, anti-cancer and gastroenterological medication therapeutic groups. A range of products covers a combination of original products Mildronate® (meldonium*) and Ftorafur®, generics, food supplements and active pharmaceutical ingredients.
In 2017 products of the company were exported to 77 countries with export comprising 92.5% of the total turnover.

Read more
https://www.youtube.com/watch?v=nV5VHuRy9Vk

Main markets

  1. 1. Japan
  2. 2. Kazakhstan
  3. 3. Russia
  4. 4. Ukraine

Target Markets

  1. 1. United States
  2. 2. Australia
  3. 3. Japan
  4. 4. Canada
  5. 5. Vietnam

In which areas are looking for cooperation

  • Pharmaceutical products
  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Products

Are you a healthcare specialist?

Yes No

URSOGRIX®

URSOGRIX® contains the active pharmaceutical ingredient ursodeoxycholic acid – a natural bile acid found in small quantities in normal human bile. It dissolves cholesterol gallstones, and increases hepatocyte membrane stabilizing and resistance functions during harmful exposure, restores damaged hepatocyte membranes, inhibits the abnormal immune response in the liver at cholestatic liver disease.

OXYTOCIN-GRINDEKS

The product contains oxytocin – a hormone used as a medication to facilitate childbirth, reduce postpartum bleeding and to stimulate lactation. The medicine contracts the smooth muscles in the womb and myoepithelial cells in mammary gland, which ensures secretion of milk from the mammary glands.

Showing similar companies

By the industry in which it operates

Map pin icon 53 Krustpils Street, Riga
Global network icon grindeks.lv

Foundation year: 1946

NACE classifier: Manufacture of pharmaceutical preparations

Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2017 to 2021.

2017 2018 2019 2020 2021
132400000 99706194 106774637 97558330 139312517

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2017 to 2021.

2017 2018 2019 2020 2021
With higher education 416 445 447 443 543
With secondary and professional education 130 139 159 153 204
Number of employees in total 678 696 736 743 920

In which areas are looking for cooperation

  • Pharmaceutical products
  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Export volume over the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Main markets

  1. 1. Japan
  2. 2. Kazakhstan
  3. 3. Russia
  4. 4. Ukraine

Target Markets

  1. 1. United States
  2. 2. Australia
  3. 3. Japan
  4. 4. Canada
  5. 5. Vietnam

Investing in R&D

Data are not able

Data are not able

Empty chart placeholder

GRINDEKS AS

Description about enterprise:

“Grindeks” is an international pharmaceutical company focused on research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The Group of “Grindeks” has four subsidiary companies in Latvia, Estonia and Slovakia as well as representative offices in 12 countries.
“Grindeks” specializes in the heart and cardiovascular, CNS, anti-cancer and gastroenterological medication therapeutic groups. A range of products covers a combination of original products Mildronate® (meldonium*) and Ftorafur®, generics, food supplements and active pharmaceutical ingredients.
In 2017 products of the company were exported to 77 countries with export comprising 92.5% of the total turnover.

Valid certificates:

EU Good Manufacturing Practice certificates for finished dosage forms and active pharmaceutical ingredients
EU Good Manufactiring Certificate for Pharmaceutical Wholesaler
Russian Certificate of good Manufacturing Practice for finished dosage forms
ISO 9001 Quality Management System Certificate
ISO 14001 Environmental Mangement Systeme Certificate
ISO 50001 Energy Management Certificate
Successful PMDA and US FDA
Saudi Food and Drug Administration Certificate

Products

Are you a healthcare specialist?

Yes No

URSOGRIX®

URSOGRIX® contains the active pharmaceutical ingredient ursodeoxycholic acid – a natural bile acid found in small quantities in normal human bile. It dissolves cholesterol gallstones, and increases hepatocyte membrane stabilizing and resistance functions during harmful exposure, restores damaged hepatocyte membranes, inhibits the abnormal immune response in the liver at cholestatic liver disease.

OXYTOCIN-GRINDEKS

The product contains oxytocin – a hormone used as a medication to facilitate childbirth, reduce postpartum bleeding and to stimulate lactation. The medicine contracts the smooth muscles in the womb and myoepithelial cells in mammary gland, which ensures secretion of milk from the mammary glands.